Vera Therapeutics
Vera Therapeutics is a clinical- and commercial-stage biopharmaceutical company based in Brisbane, California, developing treatments for serious immunological and inflammatory diseases of the kidney. Its lead program, atacicept (marketed as TRUTAKNA), is a dual BAFF/APRIL inhibitor for IgA nephropathy (IgAN). Surfaced as a portfolio company of GV and added to the API Evangelist network for enrichment, Vera Therapeutics publishes a corporate and patient-facing website (veratx.com) but exposes no public developer portal, API, SDKs, or machine-readable API surface. Sector: life-sciences.
Vera Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biopharmaceutical, Pharmaceuticals, and Nephrology.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 2
Pricing, plans, and the legal terms of use
Company 2
The organization behind the API